Library›Literature›Russell 2017 LuxturnaEfficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophySaveRussell et al. (2017). LancetResearchDescribed parts & designsAAV2 SerotypeIdentifiers & revisionDOI 10.1016/S0140-6736(17)31868-8OpenAlex W2736065260PubMed 28712537Revision 1, updated 24 October 2026